The purpose of this transmittal is to outline policy changes that the District Medicaid program will implement effective September 1, 2022, to expand access to Hepatitis C treatment by eliminating existing barriers to orally administered Direct Acting Antivirals (DAAs) used in the current treatment of chronic Hepatitis C infections for Fee-for-Service (FFS) and Managed Care Plan (MCP) enrolled beneficiaries.
dhcf
Department of Health Care Finance - DHCF
Attention DC Medicaid and Alliance Beneficiaries: Please click here to get information on the recent DHCF data incident.
- Home
- Services
- District Health Care Coverage
- Long Term Care Admin
-
Providers
- Information for Doula Providers
- Important Notice for Primary Care Providers
- Alliance Program Changes-Providers
- Conflict-Free Case Management
- Division of Program Integrity (DPI)
- Medicaid Program Integrity
- Person-Centered Planning
- Provider Information and Forms
- Provider Performance
- Rates and Reimbursements
- Telemedicine
- Innovation
- Innovation
- Policies
- Ombudsman
-
About
- DC Medical Care Advisory Committee
- Beneficiary Advisory Council
- Meet Our Executive Team
- Publications and Forms
- Americans with Disabilities Act Information
- Grievances/Appeals
- Open Government and FOIA - DHCF
- Procurement Opportunities
- Grant Opportunities
- Director's Biography
- HIPAA - Notice of Privacy Practice
- DHCF Notice of Non-Discrimination and Accessibility Requirements Statement
- Innovation Initiatives
- Managed Care Quality Strategy
- Maternal Health Projects
- Perinatal Mental Health Task Force